FDA Office of Prescription Drug Promotion (OPDP) · United States
FDA OPDP Pediatric / Geriatric Pharma Marketing
Prescription drug promotion must not depict or target age groups outside the approved indication and must include labeled age-specific risks when targeting that group.
What is FDA OPDP Pediatric / Geriatric Pharma Marketing?
Prescription drug promotion must not depict or target age groups outside the approved indication and must include labeled age-specific risks when targeting that group. Apply to prescription drug assets that depict, address or target children, adolescents or older adults. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability
general_audience, general_adults_18plus, customers, patients, seniors_62plus · Prescription Drug · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-11-06
What does this rule require?
Prescription drug promotion must not depict or target age groups outside the approved indication and must include labeled age-specific risks when targeting that group.
How can marketing teams comply?
Apply to prescription drug assets that depict, address or target children, adolescents or older adults.
What is FDA OPDP Pediatric / Geriatric Pharma Marketing?
Prescription drug promotion must not depict or target age groups outside the approved indication and must include labeled age-specific risks when targeting that group.
Who does this rule apply to?
general_audience, general_adults_18plus, customers, patients, seniors_62plus · Prescription Drug · pharma
Drug firms may not promote prescription drugs for unapproved uses; scientific information on unapproved uses may go to HCPs only if separate from promotion and accompanied by the disclosures in FDA's 2025 guidance.
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.